IMC Chicago’s Twist Bioscience TWST Stock Holding History

IMC Chicago’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,661	Closed	-$368K	–	6818
2026 Q1	$269K	Buy	+5,661	New	+$254K	﹤0.01%	4717

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

IMC Chicago's TWST Position: Q2 2026 in Review

IMC Chicago sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 5,661 shares — an estimated $368K sold.

IMC Chicago first reported a position in TWST in Q1 2026 and held it in 1 quarter. The position peaked at $269K in Q1 2026. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

IMC Chicago reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
IMC Chicago sold 5,661 Twist Bioscience shares in Q2 2026, an estimated $368K.
IMC Chicago first reported a position in Twist Bioscience in Q1 2026 and held it in 1 quarter.
IMC Chicago's Twist Bioscience position peaked at $269K in Q1 2026.
337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.